The FDA approved Corcept Therapeutics’ Lifyorli in combination with nab-paclitaxel for the treatment of three different kinds of cancer in patients who have received up to three prior lines of treatments.
The Wednesday approval came …
Merck’s drug enlicitide beat a handful of commonly used cholesterol-lowering drugs in a comparator trial, inching it closer to becoming the first oral PCSK9 inhibitor.
During this year’s American Academy of Dermatology annual meeting in Denver, companies like Sanofi, Biogen and Tanabe Pharma presented data for their respective candidates. But
Attempts by the White House to curry industry support for legislation that would codify last year’s voluntary drug pricing deals are being ignored by some
Nearly all of Incheon-headquartered Samsung Biologics’ union members have supported plans to strike over wage negotiations, after an internal employee data leak in November. The
Two decades ago, when I was a baby-faced Capitol Hill reporter, Texas Republican Michael Burgess was a relatively new member of Congress, swept in with
The FDA approved Corcept Therapeutics’ Lifyorli in combination with nab-paclitaxel for the treatment of three different kinds of cancer in patients who have received up to three prior lines of treatments.
The Wednesday approval came …